Inger Pettersen

Leder
ved Diagnostisk klinikk ved Universitetssykehuset Nord-Norge HF

Resultater Resultater

Levonorgestrel-impregnated intrauterine device as treatment for endometrial hyperplasia: A national multicentre randomised trial.

Ørbo, Anne; Vereide, Anne Beate; Arnes, Marit; Pettersen, Inger; Straume, Bjørn. 2014, BJOG: An International Journal of Obstetrics and Gynaecology. UIT, UNNVitenskapelig artikkel

The Impact of Ionizing Radiation on the Motility and Matrix Remodelling Properties of Carcinoma-associated Fibroblasts.

Hellevik, Turid; Pettersen, Inger; Winberg, Jan-Olof; Berg, Vivian; Paulssen, Ruth H; Bartnes, Kristian; Busund, Lill-Tove; Bremnes, Roy M.; Martinez, Inigo Zubiavrre. 2011, European Journal of Cancer. UIT, UNNSammendrag/abstract

Successful treatment of endometrial hyperplasia by the levonorgestrel impregnated intrauterine system coincides with down-regulated progesterone receptor A and B.

Ørbo, Anne; Arnes, marit; Pettersen, Inger; Larsen, Kurt; Hanssen, Karin Johanne; Moe, Bjørn Torvald Greve. 2011, Virchows Archiv. UITSammendrag/abstract

Expression of iNOS - A Favourable Prognostic Marker for Early-stage Carcinoma of the Uterine Cervix.

Eggen, Tormod; Sager, Georg; Arnes, Marit; Pettersen, Inger; Ørbo, Anne. 2011, Anticancer Research. UIT, UNNVitenskapelig artikkel

Prognostic markers for detection of coexistent carcinoma in high-risk endometrial hyperplasia.

Ørbo, Anne; Moe, Bjørn Torvald Greve; Arnes, Marit; Pettersen, Inger; Larsen, Kari Margrethe; Eggen, Tormod; Myrmel, Kristin Smistad; Hanssen, Karin Johanne. 2010, Anticancer Research. UIT, UNNVitenskapelig artikkel

1 - 5 av 7 | Neste | Siste »